Provided by Tiger Fintech (Singapore) Pte. Ltd.

Legend Biotech

34.63
-0.6300-1.79%
Volume:232.43K
Turnover:8.09M
Market Cap:6.35B
PE:-18.07
High:35.40
Open:34.58
Low:34.35
Close:35.26
Loading ...

Legend Biotech Corp: Appointment of Jessie Yeung as Interim CFO

THOMSON REUTERS
·
24 Dec 2024

Legend Biotech Corp: Resignation of Lori Macomber as CFO- SEC Filing

THOMSON REUTERS
·
24 Dec 2024

Exploring 3 High Growth Tech Stocks In The United States

Simply Wall St.
·
23 Dec 2024

U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity

Reuters
·
23 Dec 2024

Legend Biotech Corp : JP Morgan Cuts Target Price to $77 From $80

THOMSON REUTERS
·
23 Dec 2024

Legend Biotech management to meet with Piper Sandler

TIPRANKS
·
13 Dec 2024

Legend Biotech’s CARVYKTI® Boosts Myeloma Treatment Success

TipRanks
·
11 Dec 2024

William Blair Sticks to Its Hold Rating for Legend Biotech (LEGN)

TIPRANKS
·
10 Dec 2024

Legend Biotech Reports Advancement of Carvykti as 'Leading' Multiple Myeloma Treatment

MT Newswires Live
·
10 Dec 2024

Legend Biotech’s Phase 3 study of CARVYKTI shows ‘improved disease negativity’

TIPRANKS
·
10 Dec 2024

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Legend Biotech (LEGN) and Gilead Sciences (GILD)

TIPRANKS
·
09 Dec 2024

Legend Biotech Price Target Maintained With a $86.00/Share by RBC Capital

Dow Jones
·
09 Dec 2024

UBS Lowers Legend Biotech Price Target to $65 From $75, Maintains Buy Rating

MT Newswires Live
·
09 Dec 2024

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Disc Medicine (IRON) and BridgeBio Pharma (BBIO)

TIPRANKS
·
09 Dec 2024

Analysts Conflicted on These Healthcare Names: NeueHealth Inc (NEUE), Agilent (A) and Legend Biotech (LEGN)

TIPRANKS
·
09 Dec 2024

RBC Capital Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
09 Dec 2024